Annamaria sells TEVA 51.64: Teva Comments on Receipt of First Paragraph IV Notice for COPAXONE® 40 mg/mL (glatiramer acetate injection) Formulation
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty ... ...
26 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home